Jing Fu

3.5k total citations
80 papers, 2.5k citations indexed

About

Jing Fu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jing Fu has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Cancer Research and 21 papers in Immunology. Recurrent topics in Jing Fu's work include NF-κB Signaling Pathways (8 papers), Multi-Criteria Decision Making (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Jing Fu is often cited by papers focused on NF-κB Signaling Pathways (8 papers), Multi-Criteria Decision Making (7 papers) and Multiple Myeloma Research and Treatments (7 papers). Jing Fu collaborates with scholars based in China, United States and Netherlands. Jing Fu's co-authors include Hongyang Wang, Gutian Xiao, Jun Ye, Zhaoxia Qu, Pengrong Yan, Yao Chen, Wenhao Qin, Gen‐Sheng Feng, Feng Shen and Michael J. Grusby and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jing Fu

74 papers receiving 2.4k citations

Peers

Countries citing papers authored by Jing Fu

Since Specialization

Citations

This map shows the geographic impact of Jing Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Fu more than expected).

Fields of papers citing papers by Jing Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Fu. The network helps show where Jing Fu may publish in the future.

Co-authorship network of co-authors of Jing Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Fu. A scholar is included among the top collaborators of Jing Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Fu. Jing Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acute effects of a single bout structured resistance and combined exercise on blood glucose profile during exercise in patients with type 2 diabetes and healthy adults: A randomized crossover study 2025 ·Diabetes Research and Clinical Practice ·(unknown), Zijia Liu, Jing Fu, Peng‐Fei Shan, Jian Wang, Wen Xu	0
2	Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases 2024 ·Hepatology ·Shouzhi Yang, Jing Fu, Wenhao Qin, Ruimin Wang, (unknown), Yida Huang, Wanshan Liu, Haiyang Su, Xiaoyu Xu, Wei Chen, (unknown), (unknown), Lin Huang, Kun Qian, Hongyang Wang	7
3	The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease 2023 ·Nature Communications ·Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Gabriel M. Pagnotti, Lewis M. Brown, Stephen J. Weiss, Markus Y. Mapara, Suzanne Lentzsch	9
4	A Markov model-based cost-effectiveness analysis comparing zanubrutinib to ibrutinib for treating relapsed and refractory chronic lymphocytic leukemia 2023 ·Expert Review of Pharmacoeconomics & Outcomes Research ·(unknown), (unknown), (unknown), Yizhang Chen, (unknown), Chuang Chen, (unknown), Jing Fu, Tao Zhou, Ziye Zhou, Xiuhua Zhang	0
5	Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects 2023 ·Blood Advances ·Shirong Li, Jing Fu, Christopher J. Walker, (unknown), Divaya Bhutani, Rajshekhar Chakraborty, (unknown), Markus Y. Mapara, Yosef Landesman, Suzanne Lentzsch	6
6	MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression 2023 ·Cellular and Molecular Biology ·Qian Yang, Jing Fu, Min Wang, (unknown), Jian Fu	1
7	AAV6-Mediated Gene Therapy Prevents Developmental Dentin Defects in a Dentinogenesis Imperfecta Type Ⅲ Mouse Model 2023 ·Human Gene Therapy ·Jing Fu, Huiwen Zheng, (unknown), Guobin Yang, Zhi Chen, Guohua Yuan	0
8	Microarray-based differential expression profiling of long noncoding RNAs and messenger RNAs in formalin-fixed paraffin-embedded human papillary thyroid carcinoma samples 2019 ·Translational Cancer Research ·(unknown), (unknown), Jing Fu, Wei Huang, (unknown), Ping Pang, (unknown), Ye‐Qiong Song, (unknown), Jing–tao Dou, Yi-Ming Mu, Fulin Wang, (unknown), Zhaohui Lyu	4
9	IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation 2018 ·Blood Advances ·(unknown), Jing Fu, (unknown), Huihui Ma, Xiaoming Xu, Yong‐Guang Yang, Shi‐Xian Deng, Markus Y. Mapara, Suzanne Lentzsch	18
10	5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity 2018 ·The Journal of Antibiotics ·Shiying Zhang, Jing Fu, Belgin Dogan, Ellen Scherl, Kenneth W. Simpson	32
11	Precision diagnosis and treatment of liver cancer in China 2017 ·Cancer Letters ·Jing Fu, Hongyang Wang	238
12	Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma 2016 ·Molecular Cancer Therapeutics ·Shirong Li, Jing Fu, Caisheng Lu, Markus Y. Mapara, Shahzad Raza, Ulrich Hengst, Suzanne Lentzsch	20
13	Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes 2016 ·Cancer Research ·Geoffrey J. Markowitz, Pengyuan Yang, Jing Fu, Gregory Michelotti, Rui Chen, Jianhua Sui, Bin Yang, Wenhao Qin, Zheng Zhang, Fu‐Sheng Wang, Anna Mae Diehl, Qi-Jing Li, Hongyang Wang, Xiaofan Wang	42
14	Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response 2015 ·Scientific Reports ·Bo Wang, Xuanyi Wang, Yu‐Mei Wen, Jing Fu, Hongyang Wang, (unknown), Yan Shi, Bin Wang	11
15	MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial–mesenchymal transition 2015 ·Cancer Letters ·Jing Tang, Liang Li, Wentao Huang, Chengjun Sui, Yingcheng Yang, Ximeng Lin, Guojun Hou, Xin Chen, Jing Fu, Shengxian Yuan, Shao Li, Wen Wen, Shanhua Tang, Dan Cao, Mengchao Wu, Lei Chen, Hongyang Wang	52
16	Cyclin G1–mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression 2012 ·Hepatology ·Wen Wen, Jin Ding, Wen Sun, Jing Fu, Yao Chen, Kun Wu, Beifang Ning, Tao Han, Lei Huang, Cheng Chen, Dong Xie, Zhong Li, Gen‐Sheng Feng, Mengchao Wu, Wei‐Fen Xie, Hongyang Wang	91
17	Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway 2012 ·Nature Communications ·Azadeh Arabi, (unknown), Rui M. Branca, Johan R. Johansson, Daniel Bandarra, Moritz Haneklaus, Jing Fu, Ingrid M. Ariës, Peter Nilsson, Monique L. den Boer, Katja Pokrovskaja Tamm, Dan Grandér, Gutian Xiao, Sónia Rocha, Janne Lehtiö, Olle Sangfelt	72
18	Epigenetic Repression of PDZ-LIM Domain-containing Protein 2 2010 ·Journal of Biological Chemistry ·Zhaoxia Qu, Jing Fu, Pengrong Yan, Jing Hu, Shi‐Yuan Cheng, Gutian Xiao	57
19	p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways 2010 ·Hepatology ·Jing Fu, Yao Chen, Jie Cao, Tao Luo, You‐Wen Qian, Wen Yang, Yibin Ren, Bo Su, Guangwen Cao, Yuan Yang, Yiqun Yan, Feng Shen, Mengchao Wu, Gen‐Sheng Feng, Hongyang Wang	109
20	PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation 2009 ·Blood ·Pengrong Yan, Jing Fu, Zhaoxia Qu, Shirong Li, Takashi Tanaka, Michael J. Grusby, Gutian Xiao	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact